Putnam Investments’s Intellia Therapeutics NTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-56,513
| Closed | -$3.16M | – | 1172 |
|
|
2022
Q3 | $3.16M | Buy |
56,513
+795
| +1% | +$44.5K | 0.01% | 594 |
|
|
2022
Q2 | $2.88M | Buy |
55,718
+10,385
| +23% | +$538K | 0.01% | 669 |
|
|
2022
Q1 | $3.29M | Buy |
45,333
+915
| +2% | +$66.5K | 0.01% | 711 |
|
|
2021
Q4 | $5.25M | Buy |
44,418
+8,045
| +22% | +$951K | 0.01% | 515 |
|
|
2021
Q3 | $4.88M | Buy |
36,373
+1,127
| +3% | +$151K | 0.01% | 526 |
|
|
2021
Q2 | $5.71M | Buy |
+35,246
| New | +$5.71M | 0.01% | 487 |
|